Skip to content
Research Article Open access CC BY 4.0

Polycythemia Rubra Vera: A Case Report

. Ambika, Ujjawal Rawat, Piyush Mittal, Ajay Kumar

International Journal of Medical and Pharmaceutical Case Reports · pp. 35–39 · Published 23 Aug 2022

10.9734/ijmpcr/2022/v15i430166

Abstract

Polycythemia vera, also denoted as polycythemia rubra vera is a Philadelphia chromosome (Ph)-negative myeloproliferative neoplasm which usually affects 2.5-10 people per 100000 people. Max cases are present in people age 60 years of age, out of which 10% patients are under the age of 40. The below presented case is an original case of 37-year-old female who presented to us with this condition with a history of insomnia, Fronto- parietal headache, a systemic itch that deteriorates after a hot water bath along with loss of concentration from last 6 weeks and early satiety, discomfort in the upper right abdomen and drastic weight loss from previous one month. The blood test depicted markedly increased hemoglobin (23.8g/dl). A bone marrow biopsy was done and it was confirmed that the patient is suffering from PRV. The patient was treated with phlebotomy, aspirin, and Ruxolitinib.

Polycythemia vera ruxolitinib haemopoietic disorder philadelphia chromosome

References (13)

  1. 1 The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [DOI]
  2. 2 Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study [DOI]
  3. 3 A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline [DOI]
  4. 4 Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [DOI]
  5. 5 How I treat polycythemia vera [DOI]
  6. 6 Masked polycythemia vera diagnosed according to WHO and BCSH classification [DOI]
  7. 7 The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns [DOI]
  8. 8 Polycythemia Vera [DOI]
  9. 9 Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk‐guided management [DOI]
  10. 10 Current management strategies for polycythemia vera and essential thrombocythemia [DOI]
  11. 11 New Perspectives on Polycythemia Vera: From Diagnosis to Therapy [DOI]
  12. 12 Polycythemia vera: diagnosis, clinical course, and current management [DOI]
  13. 13 Novel Therapies in Polycythemia Vera [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

20

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.